tirzepatide vs cagrisema News Semaglutide, Tirzepatide, CagriSema, Oh My!

Medical weight loss with Zepbound (tirzepatide) in Bellevue/Kirkland

The new biosimilar drug could pose the first major challenge to Ozempic in China, where Novo Nordisks patent is set to expire in 2026.

Why low and slow is the way to go.

Menopause marks a significant milestone in a woman's life, often accompanied by various physical and emotional changes, including fluctuations in weight.

Glucagon-like peptide-1 (GLP-1) agonists are a class of medications that have gained significant attention in recent years for their ability to manage blood sugar levels and promote weight loss

Weight regain after stopping tirzepatide is common due to metabolic adaptation and return of appetite signaling